For the Inventor, By the Inventor

Enter assignee name

Woodcliff Lake, NJ, United States of America

Eisai Inc.

USPTO Granted Patents = 33

% Expired Patents = 39.4

CIPO Patents = 10

EPO Patents = 14

Trademarks = 21

Forward Citations = 153

Loading Chart...

Loading Chart...

80 inventors (with patents filed for the assignee):

Jie Zhang (9 out of 37 patents)

Weizheng Xu (8 out of 14 patents)

Dana Victor Ferraris (7 out of 18 patents)

4. Gregory S Hamilton (6 out of 97 patents)

5. Bridget Duvall (6 out of 10 patents)

6. Greg Delahanty (6 out of 6 patents)

7. Nicholas C Nicolaides (5 out of 88 patents)

8. Luigi Grasso (4 out of 72 patents)

9. Mark Vaal (4 out of 6 patents)

10. Philip M Sass (4 out of 58 patents)

11. Sergei Belyakov (4 out of 5 patents)

12. Vincent Jacob Kalish (3 out of 52 patents)

13. Takashi Tsukamoto (3 out of 22 patents)

14. Jia-He Li (3 out of 44 patents)

15. Amy Xing (2 out of 10 patents)

33 patents: Sort by Forward Citations

1. 11826399 - Chlorotoxin agents and uses thereof (2023-11-28),

2. 10539565 - Methods for determining prognosis of colorectal cancer (2020-01-21),

3. 10509037 - Monoclonal antibodies that specifically block biological activity of a tumor antigen (2019-12-17),

4. 10364284 - High affinity antibodies that neutralizeenterotoxin B (2019-07-30),

5. 10253106 - Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells (2019-04-09),

6. 10221240 - Methods for treatment of gastric cancer (2019-03-05),

7. 10053509 - Methods for inhibiting the binding of endosialin to ligands (2018-08-21),

8. 8894989 - PARP inhibitor compounds, compositions and methods of use (2014-11-25),

9. 8883787 - Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting PARP (2014-11-11),

10. 8618075 - Certain compounds, compositions and methods (2013-12-31),

11. 8609640 - Multikinase inhibitors for use in the treatment of cancer (2013-12-17),

12. 8609631 - Compositions and methods for treating cancer (2013-12-17),

13. 8470825 - Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting PARP (2013-06-25),

14. 8329666 - Compositions and methods for treating cancer (2012-12-11),

15. 8329665 - Compositions and methods for treating cancer (2012-12-11),

Eisai Inc. is a pharmaceutical company dedicated to providing innovative solutions to address unmet medical needs. With a focus on neurology and oncology, Eisai is committed to improving the lives of patients worldwide. Through research and development, Eisai strives to bring groundbreaking therapies to market and make a positive impact on global health.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

33 Patents

#3 in Woodcliff Lake, NJ

#408 in New Jersey

#10,280 in US

#20,094 in the World

Woodcliff Lake, NJ, United States of America

Eisai Inc.

Forward Citations = 153

80 inventors:

Jie Zhang (9 out of 37 patents)

Weizheng Xu (8 out of 14 patents)

Dana Victor Ferraris (7 out of 18 patents)

4. Gregory S Hamilton (6 out of 97 patents)

5. Bridget Duvall (6 out of 10 patents)

Please report any incorrect information to [email protected]

Loading…